18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis

被引：40
|
作者：
Skali, Hicham [1 ,2 ]
Schulman, Allison R. [3 ]
Dorbala, Sharmila [1 ,2 ]
机构：
[1] Dept Radiol, Div Nucl Med & Mol imaging, Boston, MA 02115 USA
[2] Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
来源：
CURRENT CARDIOLOGY REPORTS | 2013年 / 15卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Cardiac sarcoidosis; F-18-FDG; PET; Myocardial sarcoidosis; POSITRON-EMISSION-TOMOGRAPHY; CARDIAC SARCOIDOSIS; LOW-CARBOHYDRATE; DISEASE-ACTIVITY; HIGH-FAT; INVOLVEMENT; DIAGNOSIS; PATIENT; UTILITY; HEART;
D O I：
10.1007/s11886-013-0352-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cardiac involvement portends a poor prognosis in patients with sarcoidosis. However, due to the nonspecific clinical manifestations of the disease, patchy myocardial involvement, and the limited diagnostic yield of diagnostic tests, early diagnosis of cardiac sarcoidosis has been exceedingly difficult. As a result, there is no standardized approach for the early diagnosis of cardiac sarcoidosis. Imaging modalities that can both identify disease and predict response to therapy are paramount to improve management of cardiac sarcoidosis. F-18-FDG PET has many practical advantages in assessing disease activity and monitoring treatment response in patients with cardiac sarcoidosis. Accumulating data support the growing role of F-18-fluorodeoxyglucose (F-18-FDG) PET in the diagnosis and risk stratification of patients with cardiac sarcoidosis.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Normal uptake of 18F-FDG in the testis:: an assessment by PET/CT
    Kitajima, Kazuhiro
    Nakarnoto, Yuji
    Senda, Michio
    Onishi, Yumiko
    Okizuka, Hiromi
    Sugitnura, Kazuro
    ANNALS OF NUCLEAR MEDICINE, 2007, 21 (07) : 405 - 410
  • [32] Response assessment in relapsing polychondritis with 18F-FDG PET/CT
    Jain, T. K.
    Sood, A.
    Sharma, A.
    Basher, R. K.
    Bhattacharya, A.
    Mittal, B. R.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (02): : 124 - 125
  • [33] Malignant involvement of the spine:: Assessment by 18F-FDG PET/CT
    Metser, U
    Lerman, H
    Blank, A
    Lievshitz, G
    Bokstein, F
    Even-Sapir, E
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (02) : 279 - 284
  • [34] 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
    Krause, Bernd J.
    Herrmann, Ken
    Wieder, Hinrich
    zum Bueschenfelde, Christian Meyer
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 89S - 96S
  • [35] 18F-FDG PET/MRI versus 18F-FDG PET/CT for the diagnosis of pituitary adenoma
    Wang, Hao
    Zhao, Xiaobin
    Zang, Jie
    Zhu, Zhaohui
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [36] 18F-FDG PET/CT for Response Assessment in Lung Cancer
    Marcus, Charles
    Tajmir, Shahein H.
    Rowe, Steven P.
    Sheikhbahaei, Sara
    Solnes, Lilja B.
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (06) : 662 - 672
  • [37] Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT
    Rampin, L.
    Musto, A.
    Marzola, M. C.
    Tadayyon, S.
    Ferretti, A.
    Chondrogiannis, S.
    Grassetto, G.
    Rubello, D.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (03): : 190 - 192
  • [38] Ocular Sarcoidosis Does 18F-FDG PET/CT Have Any Role?
    Jung, Rayamajhi Sampanna
    Mittal, Bhagwant Rai
    Maturu, Nagarjuna V.
    Kumar, Rajender
    Bhattacharya, Anish
    Gupta, Dheeraj
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (05) : 464 - 466
  • [39] 18F-FDG PET/CT in sarcoidosis management:: review and report of 20 cases
    Braun, Jean Jacques
    Kessler, Romain
    Constantinesco, Andre
    Imperiale, Alessio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (08) : 1537 - 1543
  • [40] Assessment of Ovarian Teratoma and Lymphadenopathy by 18F-FDG PET/CT
    Balink, Hans
    Apperloo, Mirjam J. A.
    Collins, James
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (08) : 804 - 806
12345